Back to search
FDAFDA · Food and drugs·Recall number D-686-2013

Gentamicin Sulfate Injection USP 80 mg/2 mL(40 mg/mL as Gentamicin), 2 mL Single-dose Fliptop Vial, (NDC 0409-1207-13), Rx only, Manufactured by Hospira, Inc, Lake Forest, IL 60046 USA.

Published July 17, 2013 · Recall initiated: May 2, 2013

Summary

FDA records drug Class II recall D-686-2013, published July 17, 2013 and initiated May 2, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 168,300 vals; Lot: Lot 07-067-DK Exp. 07/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: visible particles were identified floating in the primary container.

What to do

Voluntary: Firm initiated · Letter

Get an email if GENTAMICIN SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GENTAMICIN SULFATE
Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot 07-067-DK Exp. 07/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gentamicin Sulfate Injection USP 80 mg/2 mL(40 mg/mL as Gentamicin), 2 mL Single-dose Fliptop Vial, (NDC 0409-1207-13), Rx only, Manufactured by Hospira, Inc, Lake Forest, IL 60046 USA. recalled?

Yes. FDA published recall D-686-2013 on July 17, 2013. Reported hazard: Presence of Particulate Matter: visible particles were identified floating in the primary container.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GENTAMICIN SULFATE.